BRKR
Bruker Corporation
NASDAQ · USHealthcareMedical - Devices
$56.17-3.54%
Price as of Jul 20, 2026
BRKR profitability
Bruker Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 45.6%
- EBITDA margin
- 8.8%
- EBIT margin
- 5.9%
- Net margin
- -0.3%
- Free cash flow margin
- 1.5%
Returns
- Return on equity
- -0.5%
- Return on assets
- -0.2%
- Return on invested capital
- 4.9%
- Asset turnover
- 0.56x
Cash efficiency
- Cash from operations
- $140.3M
- Cash per share
- $0.86
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.